GentiBio, Inc
2 clinical trials · 2 recruiting · INDUSTRY
Trials by GentiBio, Inc
RECRUITINGPhase 1NCT06919354
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an...
Sponsor: GentiBio, IncEnrolling: 1610 locations
Type 1 Diabetes (T1D)Type 1 Diabetes Mellitus
RECRUITINGNCT06860516
HLA Demographics Study in Adults With Type 1 Diabetes
This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
Sponsor: GentiBio, IncEnrolling: 505 locations
Diabetes Mellitus, Type I